Skip to content

Net Income at other companies

Abbott logo
AbbottABT
$928M-47.8%
Artivion logo
ArtivionAORT
$1.42M+381%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$41M+36.0%
ICU Medical logo
ICU MedicalICUI
$30.13M+295%
Boston Scientific logo
Boston ScientificBSX
$905M+13.8%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$15.68M+42.4%

Other financials

Income statement

See full
Revenue$1.7B+13.6%
Gross profit$1.3B+13.5%
Operating income$513.2M+24.8%
Net income$241.9M-27.4%
EPS (diluted)$0.42-25.0%

Balance sheet

See full
Cash & equivalents$2.4B-22.3%
Total debt$702.9M+0.5%
Total equity$10.3B+2.0%
Total assets$13.3B+2.3%

Cash flow

See full
Operating cash flow$43.8M-84.4%
CapEx$64.9M+15.9%
Free cash flow-$21.1M-109%

Valuation

See full
Market cap$48.18B+3.7%
Enterprise value$46.44B+11.0%
P/E48×+36.7×
P/S7.4×-0.8×

Profitability

See full
Gross margin77.8%-1.0pp
Operating margin22.3%-3.6pp
Net margin15.4%-57.5pp
FCF margin17.3%

Returns & leverage

See full
Return on equity10.7%-37.8pp
Debt / equity0.1×0.0×
Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Edwards Lifesciences’s 8-K, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edwards Lifesciences's net income?
Edwards Lifesciences (EW) reported net income of $241.4M in Q2 2026.
How has Edwards Lifesciences's net income changed year-over-year?
Edwards Lifesciences's net income decreased by 27.2% year-over-year, from $331.5M to $241.4M.
What is the long-term trend for Edwards Lifesciences's net income?
Over 4 years (2021 to 2025), Edwards Lifesciences's net income has grown at a -8.2% compound annual growth rate (CAGR), from $1.5B to $1.07B.
What does net income mean?
Net income as the starting point for the indirect method operating cash flow reconciliation.